Wednesday, November 18, 2026 Daily Briefing News Quiz
Just in

Topics

Ozempic

Every story about Ozempic, updated as news breaks.

3 stories·Updated

What to know

  • FDA warns of NAION risk with GLP‑1 receptor agonists Nov 10
  • Over 125 trials show about 6 cases per 100,000 users after one year Nov 10
  • FDA added new warnings to Ozempic, Zepbound, Wegovy and Mounjaro for NAION risk. Nov 9
  • Patients should watch for sudden vision loss or blurred vision and report changes immediately. Nov 9
  • Retatrutide reduced A1C 2.2% after 80 weeks, higher than Ozempic’s 1.8%. Oct 28

Timeline

  1. Nov 10, 2026
  2. Nov 9, 2026
  3. Oct 28, 2026